| CYHB2100227 | 替格瑞洛片 | ticagrelor | Tablet | Chemical Drugs(4) | Supplementary Application | 2021-02-08 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2021-09-23 | view |
| CYHS2100054 | 克唑替尼胶囊 | crizotinib | Capsule | Chemical Drugs(4) | Generic Drug | 2021-01-13 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | In Review | 2021-01-12 | view |
| CYHS2100053 | 克唑替尼胶囊 | crizotinib | Capsule | Chemical Drugs(4) | Generic Drug | 2021-01-13 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | In Review | 2021-01-12 | view |
| CXSS2000034 | 重组赖脯胰岛素注射液 | insulin lispro | Injection | Biological Products(15) | New Drug Application | 2020-06-28 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | In Review | 2020-06-24 | view |
| CXSL2000109 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(15) | New Drug Application | 2020-05-30 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | In Review | 2020-05-29 | view |
| CXSL2000110 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(15) | New Drug Application | 2020-05-30 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | In Review | 2020-05-29 | view |
| CYHB2002803 | 非布司他片 | febuxostat | Tablet | Chemical Drugs | Supplementary Application | 2020-04-27 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2020-09-10 | view |
| CXHB2000027 | 丁二酸复瑞替尼胶囊 | SAF-189s | Capsule | Chemical Drugs | Supplementary Application | 2020-04-15 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | In Review | 2020-04-14 | view |
| CXHB2000028 | 丁二酸复瑞替尼胶囊 | SAF-189s | Capsule | Chemical Drugs | Supplementary Application | 2020-04-15 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | In Review | 2020-04-14 | view |
| CXSS2000009 | 重组甘精胰岛素注射液 | insulin glargine | Injection | Biological Products(15) | New Drug Application | 2020-03-19 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | In Review | 2020-03-17 | view |
| CYSB2000033 | 重组人胰岛素注射液 | human insulin | Injection | Biological Products | Supplementary Application | 2020-03-14 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2021-12-15 | view |
| CYHB2050015 | 替米沙坦片 | telmisartan | Tablet | Chemical Drugs | Supplementary Application | 2020-01-16 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2020-12-21 | view |
| CXSL1900149 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products(7) | New Drug Application | 2019-12-26 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | In Review | 2019-12-25 | view |
| CYHS1900797 | 注射用帕瑞昔布钠 | parecoxib sodium | Lyophilized | Chemical Drugs(4) | Generic Drug | 2019-11-23 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2021-01-26 | view |
| CYHS1900781 | 枸橼酸托法替布片 | tofacitinib citrate | Tablet | Chemical Drugs(4) | Generic Drug | 2019-11-20 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | In Review | 2019-11-19 | view |
| CYHB1950424 | 非布司他片 | febuxostat | Tablet | Chemical Drugs | Supplementary Application | 2019-06-14 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2020-04-16 | view |
| CYHB1950425 | 非布司他片 | febuxostat | Tablet | Chemical Drugs | Supplementary Application | 2019-06-14 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2020-04-16 | view |
| CYHB1950416 | 匹伐他汀钙片 | pitavastatin calcium | Tablet | Chemical Drugs | Supplementary Application | 2019-06-12 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2020-04-22 | view |
| CYHB1950415 | 匹伐他汀钙片 | pitavastatin calcium | Tablet | Chemical Drugs | Supplementary Application | 2019-06-12 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2020-04-22 | view |
| CYHS1900393 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2019-06-10 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2021-02-05 | view |
